Flow Cytometry Confirmation Post Newborn Screening for SCID in England
An evaluation program for newborn screening for Severe Combined Immunodeficiency began in England in September 2021 based on TREC analysis. Flow cytometry is being used as the follow up diagnostic test for patients with low/absent TRECS. The immunology laboratories have established a protocol and va...
Main Author: | Kimberly C. Gilmour |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/8/1/1 |
Similar Items
-
Need for Uniform Definitions in Newborn Screening for SCID: The Next Challenge for Screeners and Immunologists
by: Mirjam van der Burg
Published: (2021-08-01) -
Follow-Up for an Abnormal Newborn Screen for Severe Combined Immunodeficiencies (NBS SCID): A Clinical Immunology Society (CIS) Survey of Current Practices
by: Vijaya Knight, et al.
Published: (2020-06-01) -
Establishing Newborn Screening for SCID in the USA: Experience in California
by: Jennifer M. Puck, et al.
Published: (2021-10-01) -
Study Design for an Evaluation of Newborn Screening for SCID in the UK
by: David Elliman
Published: (2022-01-01) -
Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program
by: Maartje Blom, et al.
Published: (2018-12-01)